News
Brazil has developed a substance with the potential to “cure” paralysis caused by spinal cord injury, but has lost international patents for polylaminin after budget cuts at UFRJ and 18 years of delays at INPI (National Institute of Industrial Property).
The day a paralyzed mouse stood up and walked again, the world of spinal cord injury research held its breath. In a small lab at...